%PDF-1.4
%
46 0 obj
<>
endobj
48 0 obj
<>stream
2016-10-27T14:52:44-05:00
QuarkXPress(R) 9.3
2024-03-28T11:41:51-07:00
2024-03-28T11:41:51-07:00
QuarkXPress(R) 9.3
application/pdf
Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
%%DocumentProcessColors: Black
%%EndComments
uuid:905810eb-1dd2-11b2-0a00-740827bd7200
uuid:9058111a-1dd2-11b2-0a00-880000000000
endstream
endobj
10 0 obj
<>]>>
endobj
39 0 obj
<>
endobj
40 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
41 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
42 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
43 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
44 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
45 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
75 0 obj
[80 0 R]
endobj
76 0 obj
<>stream
Hrm٢mRxL
T67VnREjy+LL%[4p==_{G)G_W1MgIo>{O]s0Fe_e;&`ʭy\h
64P{^fZe[z[8q?)n=2JOz(ϴ^ph85S0Y=?3#=TKkEc='Dl'Dz sNZ'1qGGw{ןi~95/'4+:vq/bHvKGcܴexdhҶ˾{8@N;w0<;h]Mv&tZueЏ:yhщV |H#6z- g=G:YNgrʯ/4m[
h+ypMr#J<*=99NEz5hWy֤<7c$M:wӝ{:GxD* ,2t>fsq*y 셜KcDVO?0ʆO֞Iͮs@Gx"m1mٱh\azb)ą
Yɨ8cn>
f;7"#8gqz`
"Sϰ9W(Od ;3=A
rm&aBgtNѿuZ jY290hKS&xόg'O